title: Zimelidine decreases seizure susceptibility in stressed mice.
abstract: To further evaluate whether selective serotonin reuptake inhibitors (SSRIs) have pro- or anticonvulsant properties and whether these properties will be modified by stress, we studied the effect of zimelidine on the convulsions produced by picrotoxin, a GABA(A) receptor antagonist, in unstressed and swim stressed mice. Zimelidine potentiated the ability of swim stress to enhance the threshold doses of intravenously administered picrotoxin producing convulsant signs and death, without having an effect in unstressed mice. The anticonvulsant effect of zimelidine was counteracted with mianserin, the antagonist of 5-HT(2A/2C), and diminished with WAY-100635, a selective antagonist of 5-HT(1A) receptors. In stressed mice, WAY-100635 prevented the anticonvulsant effect of 8-OH-DPAT, a 5-HT(1A) receptor agonist. SB-269970 and ketanserin, the antagonists of 5-HT(7) and 5-HT(2A) receptors, respectively, failed to reduce the effect of zimelidine. The results suggest the involvement of 5-HT(2C) and 5-HT(1A) receptors in the anticonvulsant effects of zimelidine and possibly other SSRIs in stress.
authors.affiliation: Laboratory for Molecular Neuropharmacology, Division of Molecular Medicine, Ruder Bosković Institute, Zagreb, Croatia. pericic@irb.hr
authors.forename: D
authors.initials: D
authors.lastname: Pericić
authors.forename: D S
authors.initials: DS
authors.lastname: Strac
authors.forename: J
authors.initials: J
authors.lastname: Vlainić
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants; D001522:Behavior, Animal / Q000187:drug effects; D003292:Convulsants / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007650:Ketanserin / Q000494:pharmacology; D008297:Male; D008803:Mianserin / Q000494:pharmacology; D051379:Mice; D008808:Mice, Inbred CBA; D010636:Phenols / Q000494:pharmacology; D010852:Picrotoxin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D012640:Seizures / Q000209:etiology* / Q000517:prevention & control*; D012702:Serotonin Antagonists / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D013315:Stress, Psychological / Q000150:complications*; D013449:Sulfonamides / Q000494:pharmacology; D013550:Swimming / Q000523:psychology; D015031:Zimeldine / Q000494:pharmacology*
chemical_list: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000927:Anticonvulsants; D003292:Convulsants; D007650:Ketanserin; D008803:Mianserin; D010636:Phenols; D010852:Picrotoxin; D010879:Piperazines; D011725:Pyridines; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D017367:Selective Serotonin Reuptake Inhibitors; D013449:Sulfonamides; D015031:Zimeldine; C404922:SB 269970; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide